Skip to content

Evaluation of the Effects of Virtual Reality on Preoperative Anxiety in Refractive Surgery

Evaluation of the Effects of Virtual Reality on Preoperative Anxiety in Refractive Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07050498
Acronym
ERVAN
Enrollment
68
Registered
2025-07-03
Start date
2024-09-18
Completion date
2026-09-18
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Disorders

Keywords

refractive surgery

Brief summary

The objective of this study is to determine to what extent the use of a software application prior to refractive surgery involving multisensory immersion (visual and auditory) in a hypnotic and relaxing sound and visual environment can reduce anxiety levels. The assessment of preoperative anxiety levels will be based on the administration of a psychometric scale (APAIS scale) and the measurement of salivary cortisol, which is a sensitive marker of the patient's stress level.

Detailed description

This is a prospective, randomized, open-label, single-center study conducted on two parallel groups of patients undergoing refractive surgery (virtual reality preoperative conditioning or routine preoperative procedure). Therapeutic benefit is based on the assessment of preoperative anxiety using the APAIS scale.

Interventions

DEVICEVirtual reality

Virtual reality hypnosis software applications are Class I medical devices according to Rule 12 of Directive 93/42/EC. They allow, through a virtual reality headset and headphones, to immerse the patient in a hypnotic sound and visual environment. Several visual scenarios can be proposed, allowing the patient to virtually travel to a beach, the seabed, on an alpine walk, etc.). The HypnoVR Biofeedback virtual reality device is provided by the HypnoVR company.

PROCEDUREUsual Care Group

Routine preoperative procedure (local anesthesia)

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-center, prospective, randomized, open-label study on two parallel groups of patients

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 years or older, * Patient who has read and signed the consent form for participation in the study after a reflection period (between 10 and 45 minutes) * Patient who is a candidate for refractive surgery

Exclusion criteria

* Contraindication to virtual reality (uncontrolled epilepsy, hearing impairment) * Pregnant or breastfeeding patient * Cushing's disease, Addison's disease, hypo- or hyperthyroidism * Patient treated with topical or systemic corticosteroids * Patient treated with neuroleptics, anxiolytics, or antidepressants * Patient under legal protection, guardianship, or curatorship * Patient participating in another blinded research study * Patient not affiliated with the French social security system * Patient unable to understand the information provided and/or give written informed consent: dementia, psychosis, impaired consciousness, non-French-speaking patient

Design outcomes

Primary

MeasureTime frameDescription
Preoperative anxiety levelPreoperative procedureThe preoperative anxiety level is measured on the APAIS scale. The APAIS scale is a self-assessment consisting of six questions with expected responses rated from 1 (the patient strongly disagrees with the statement) to 5 (the patient strongly agrees with the statement) out of a minimum overall score of 6 and a maximum overall score of 30. The first three questions relate to anesthesia, and the next three relate to surgery. Of the three questions (related to anesthesia or surgery), two assess preoperative anxiety, and the third assesses the need for information. The APAIS scale calculates four scores: overall anxiety, surgery-related anxiety, anesthesia-related anxiety, and information need. A total anxiety score of 11 or higher corresponds to a high level of anxiety.

Secondary

MeasureTime frameDescription
Postoperative pain intensity15 minutes after the End of surgeryPain intensity will be assessed using a simple numerical rating scale (SNR) ranging from 0 (no pain) to 10 (worst imaginable pain).
Intraoperative comfort15 minutes after the End surgeryComfort will be assessed using a simple numerical rating scale (SNR) ranging from 0 (minimum comfort) to 10 (maximum comfort).
Postoperative Overall Patient Satisfaction15 minutes after the End of surgeryOverall Patient Satisfaction will be assessed using a simple numerical rating scale (SNR) ranging from 0 (not at all satisfied) to 10 (very satisfied).
Intraoperative pain intensityImmediately after surgeryPain intensity will be assessed using a simple numerical rating scale (SNR) ranging from 0 (no pain) to 10 (worst imaginable pain).
Heart rateBefore any study procedureHeart rate measurement in both groups
Blood pressureBefore any study procedureBlood pressure measurement in both groups
Tolerance15 minutes after the end of surgeryThe tolerance of the test procedure will be assessed by collecting adverse events occurring during the duration of the study.
Change in salivary cortisolBefore any study procedureAfter rinsing the mouth with water, a 1 ml sample of salivary secretions without stimulation will be taken using a Salivette® (Sarstedt TM). The samples will be stored at -20°C before being analyzed by the private laboratory Eurofins, using an ELISA test (analytical sensitivity = 1.38 nmol/L; functional sensitivity = 8.28 nmol/L; upper detection limit \ 110 nmol/L).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026